Is ARFID more common in autistic people?

Yes, and the prevalence gap is substantial. Studies summarized by Sharp and colleagues (2013) found that up to 70 percent of autistic children exhibit food selectivity significant enough to raise clinical concern, compared with roughly 25 percent of non-autistic children. A 2021 review by Koomar and colleagues in Frontiers in Psychiatry documented that ARFID diagnoses co-occur with autism at rates between 12 and 32 percent across clinical samples, depending on the screening instrument used. The direction also runs the other way. Adults presenting for ARFID evaluation screen positive for autism at rates several times higher than the general population, particularly women who were missed in childhood.

Why do autistic adults often have low appetite or miss hunger cues?

The mechanism is interoceptive. Interoception is the brain's capacity to detect internal body states, including hunger, thirst, fullness, and fatigue. Research led by Nancy Zucker at Duke and by Sarah Garfinkel at University College London documents that autistic individuals often show reduced accuracy in identifying these signals, a pattern that also appears in the low-interest subtype of ARFID described by Jennifer Thomas and Kamryn Eddy. An autistic adult who never feels hunger is not refusing food. The signal that prompts eating in neurotypical people is arriving faintly or not at all. Eating becomes a scheduled task rather than a response to a bodily cue.

Can an autistic person have ARFID treatment that actually works?

Yes, but the treatment needs to account for autistic neurology rather than treating sensory responses as cognitive distortions to be corrected. CBT-AR, developed by Thomas and Eddy, adapts well when clinicians pace exposure to the client's actual sensory threshold, use concrete and literal language, reduce surprise at mealtimes, and coordinate with occupational therapy for sensory regulation. Traditional eating disorder treatment built around weight restoration and body image work often fails this population because it targets mechanisms that were never the problem. A clinician who understands both the ARFID three-dimensional model and autistic sensory processing can deliver exposure work that respects the neurological floor rather than trying to argue past it.

ARFID and Autism: Where the Overlap Actually Lives

TL;DR: ARFID and autism share a neurological substrate. Sensory processing differences, reduced interoceptive accuracy, and heightened autonomic reactivity produce food avoidance in both the sensory-primary presentation common in autistic children and the low-interest presentation common in late-diagnosed autistic adults. Dual assessment and neurology-aware treatment matter more than matching surface symptoms.

Two Evaluations, Two Weeks Apart

On a Tuesday in October, an eleven-year-old boy sits in an outpatient eating disorder clinic in Pittsburgh. His parents have brought a list. He eats five foods: a specific brand of chicken nugget, plain white rice, Ritz crackers, apple slices with the skin removed, and a single flavor of Gogurt. He has eaten these five foods for four years. His pediatrician ordered labs six months ago. Ferritin was 12 ng/mL. Vitamin D was 18 ng/mL. Zinc was at the low end of reference range. He is in the fifteenth percentile for weight, down from the fiftieth at age seven. The intake clinician, who trained in the three-dimensional ARFID model, adds an autism screening instrument to his evaluation protocol before the appointment.

Two weeks later, a thirty-seven-year-old woman sits in the same clinic. She has come because her primary care doctor, running out of explanations for persistent low body weight, iron deficiency, and what she describes as a lifetime of not quite understanding when other people say they are hungry, referred her for an eating disorder evaluation. She says she forgets to eat. She says meals feel like administrative tasks she schedules on her calendar. She has never binged, never purged, never counted calories. She describes a childhood of being called picky and a marriage in which her husband cooks because she genuinely does not notice the passage of hours without food. The clinician adds the same autism screening instrument to her evaluation.

The boy screens positive. The woman screens positive. Both receive a recommendation for a full autism diagnostic evaluation alongside ARFID treatment planning.

The surface presentations look nothing alike. What the clinician is actually looking at, in both cases, is the same neurological substrate producing two different patterns of food avoidance across two different lifespans.

The Shared Substrate

ARFID was added to the DSM-5 in 2013, the same revision that collapsed the previous autism subtypes into a single spectrum diagnosis. The timing was not coincidental. Both diagnoses reflect a shift in how developmental psychiatry conceptualizes sensory processing, interoceptive awareness, and autonomic reactivity as core features of neurology rather than as peripheral quirks.

Three mechanisms connect ARFID and autism at the neurological level.

Sensory processing differences

Sally Ozonoff’s research at UC Davis, extending earlier work by Polly Kuschner and others, established sensory processing differences as a core feature of autism observable in infancy, measurable through standardized instruments such as the Sensory Profile, and present in roughly 90 percent of autistic individuals. Temple Grandin, writing from her own autistic perspective in Thinking in Pictures, describes the sensation of a scratchy shirt tag as genuinely painful rather than mildly annoying. The threshold is different at the level of neural processing, not at the level of interpretation.

Food is a sensory event. Every bite involves simultaneous input from the trigeminal nerve (texture, temperature, pressure), the olfactory system (aroma before and during chewing), the gustatory system (taste on different regions of the tongue), the visual system (appearance on the plate), and proprioception (how the jaw moves, how the food shifts). For a person whose sensory processing runs with different thresholds, a mouthful of yogurt is not neutral data. It is a flood of input the nervous system registers as potentially aversive.

Jennifer Thomas and Kamryn Eddy’s three-dimensional ARFID model, developed at Massachusetts General Hospital and operationalized through the Pica, ARFID, and Rumination Disorder Interview, identifies sensory sensitivity as one of three primary ARFID mechanisms. In autistic children, this mechanism predominates. The boy with five foods is avoiding not flavors but textures, temperatures, visual configurations, and the unpredictability of food that deviates from a known sensory profile.

Interoceptive accuracy

The second mechanism lives deeper in the body. Interoception is the nervous system’s capacity to detect internal states: hunger, thirst, fullness, fatigue, the need to urinate, the pace of the heartbeat. Nancy Zucker’s laboratory at Duke, along with researchers including Sarah Garfinkel and colleagues at University College London, has documented that interoceptive accuracy varies substantially across individuals and tracks with both autism and ARFID in ways that clinicians who treat eating disorders have only recently started to recognize.

An autistic adult who says she does not experience hunger is reporting accurately. The hunger signal, mediated by ghrelin and registered through the insular cortex, is arriving with less clarity or with different threshold dynamics than in neurotypical peers. Thomas and Eddy’s low-interest ARFID subtype describes exactly this pattern: eating requires a motivational signal that simply does not fire at the expected intensity or frequency. Food becomes cognitively managed rather than viscerally pursued.

The woman who sits in the clinic at thirty-seven has been managing around a faint hunger signal her entire life. In childhood, parents and teachers provided external structure that kept her fed. In adulthood, that structure disappeared. Her body weight drifted downward. Her ferritin dropped. She was not restricting food in any intentional sense. The signal that prompts eating was failing to register in time to matter.

Autonomic reactivity

The third mechanism involves the autonomic nervous system’s response to food-related stimuli. Rachel Bryant-Waugh’s research on ARFID development, conducted over more than two decades at Great Ormond Street Hospital in London, emphasizes that food avoidance often originates in an early experience of autonomic threat: choking, severe vomiting, a traumatic medical procedure involving the mouth or throat. Once the autonomic system has classified food as a potential threat, the subsequent response is not a cognitive decision but a physiological cascade.

Autistic individuals often show heightened autonomic reactivity at baseline, a pattern documented in heart rate variability research and skin conductance studies. This means an experience that a neurotypical nervous system would recover from quickly can leave a more durable imprint in an autistic nervous system. The fear-based ARFID subtype in autistic children is often especially persistent because the original autonomic learning happened in a system primed to register threat more intensely and extinguish it more slowly.

Why the Adult Women Keep Arriving

The late-diagnosed autistic woman presenting with lifelong low appetite, narrow food range, or chronic iron deficiency is now a recognizable pattern in eating disorder practice. The pathway into the clinic typically runs through a primary care physician who has exhausted medical explanations for weight or nutrient findings that do not fit any obvious somatic diagnosis.

Several factors converge to produce this pattern. Autism in women and girls was systematically underdiagnosed through the 1990s and 2000s because diagnostic criteria had been developed on largely male samples. Girls who masked social differences effectively, who had verbal intelligence in the normal or superior range, and who did not display the stereotyped behaviors associated with the classic presentation were missed. Food-related difficulties in these girls were filed under picky eating, anxiety, or in some cases misdiagnosed as restrictive anorexia despite the absence of body image concerns.

These same women, now in their thirties and forties, arrive at eating disorder clinics with presentations that do not match anorexia nervosa. They have no fear of weight gain. They often wish they could eat more. The restriction pattern has been stable for decades rather than progressive. When a clinician trained in both ARFID and autism conducts the evaluation, the neurological pattern becomes visible. The low-interest ARFID subtype and previously undiagnosed autism tend to appear together.

Why Traditional Eating Disorder Treatment Fails This Intersection

Treatment built around weight restoration protocols, cognitive restructuring of body image distortions, and family-based therapy targeting the anorexic mindset targets mechanisms that are not operating in this population. The autistic adult with ARFID does not have cognitive distortions about her body. Her weight is low because her nervous system does not reliably signal hunger, her sensory thresholds narrow the acceptable food range, and her autonomic system treats unfamiliar food as a threat.

When a treatment team pushes this patient through a standard eating disorder protocol, several failures follow. The exposure pace, calibrated for a neurotypical system, overwhelms her sensory threshold and produces autonomic responses the treatment team misreads as resistance. Cognitive restructuring exercises aimed at correcting beliefs she does not hold feel irrelevant or invalidating. Group therapy built around shared experience of body image distress alienates her further.

CBT-AR, as developed by Thomas and Eddy, addresses the three-dimensional ARFID model directly and adapts well to autistic clients when delivered with appropriate pacing, literal language, and sensory accommodations. Graduated exposure works when each step changes one variable at a time, when the clinician respects the autonomic floor rather than trying to push past it, and when occupational therapy for sensory regulation operates alongside the food work.

What Dual Assessment Looks Like

When an ARFID evaluation produces a positive result, a competent clinician now asks a second question: is autism also present? The reverse also holds. An autism evaluation that uncovers a history of severe food selectivity, unexplained weight loss, or lifelong low appetite triggers an ARFID screen.

The instruments used in dual assessment include the Pica, ARFID, and Rumination Disorder Interview for the eating side, the Autism Diagnostic Observation Schedule or the Autism Quotient for the autism side, and the Sensory Profile or the Adolescent/Adult Sensory Profile to map the sensory dimension that crosses both diagnoses. The interoceptive dimension is harder to assess in routine practice, though the Body Perception Questionnaire and the Multidimensional Assessment of Interoceptive Awareness capture parts of it.

Dual assessment matters because the treatment plan changes. A child with ARFID alone may progress through CBT-AR at a pace calibrated to a neurotypical sensory system. A child with ARFID and autism benefits from a slower pace, occupational therapy coordination, and parent coaching that accounts for autistic family dynamics. A late-diagnosed autistic adult with low-interest ARFID benefits from external eating structures, interoceptive awareness training, and medical monitoring rather than from a protocol built for restrictive anorexia.

Questions to Ask a Clinician

Parents evaluating clinicians for a child with suspected ARFID and autistic traits, or adults seeking evaluation for themselves, can ask a small number of questions that surface how the clinician thinks about the intersection.

Does the clinician use the three-dimensional ARFID model developed by Thomas and Eddy? Does she distinguish between sensory-primary, fear-based, and low-interest presentations, or does she treat ARFID as a single syndrome? Does she routinely add an autism screening instrument when ARFID is identified? Does she coordinate with occupational therapy for sensory regulation? Has she worked with late-diagnosed autistic adults, and if so, what does her treatment pathway look like for that population?

A clinician who can answer these questions in specific terms is working at the intersection. A clinician who treats ARFID as a version of anorexia or treats autism as irrelevant to the eating pattern is working one dimension short of what the neurology requires.

Where This Leaves the Two Evaluations

The boy will begin CBT-AR with occupational therapy running in parallel. His family will meet with a parent coach who understands both the ARFID exposure structure and the autistic nervous system. His ferritin will be supplemented while the food work expands his range. In six months, the safe food list will be seven or eight items rather than five. In two years, it may be fifteen. The goal is not neurotypical eating. The goal is a sensory range wide enough to meet nutritional needs and narrow enough to respect the neurology he actually has.

The woman will begin interoceptive awareness training, learn to schedule meals in a way that compensates for the missing hunger signal, and receive iron infusions to restore her ferritin. She will also receive her first formal autism diagnosis at thirty-seven, which will recontextualize three decades of medical notes that described her as underweight for unclear reasons. Her husband will stop worrying that she is dying of something no one can find.

Neither of them will be cured, because neither of them has a disease in the sense that cure applies. They have a neurology that produces food avoidance through mechanisms the field has only recently started to map. What they have now is a treatment framework calibrated to the substrate that actually generates the symptoms, rather than a protocol designed for a different condition entirely.

Further reading on the sensory dimension is available in the post on ARFID and sensory sensitivity. For the distinction between clinical ARFID and ordinary picky eating, see ARFID vs picky eating. A full diagnostic overview is available in what is ARFID. The eating disorders assessment and the autism screening assessment can serve as a first step for anyone whose presentation resembles either of the two evaluations above. The ARFID course covers the three-dimensional model in depth across eleven modules.

If the pattern in this post matches what you or your child are living with, a consultation is the next step.